|
|
| | pre-Calcitriol PTAD Adduct Basic information |
| Product Name: | pre-Calcitriol PTAD Adduct | | Synonyms: | pre-Calcitriol PTAD Adduct;[4aR-[4aα,6aα,7α(R*),9aβ,11α(3S*,5R*)]]-11-(3,5-Dihydroxy-2-Methyl-1-cyclohexen-1-yl)-4a,6,6a,7,8,9,9a,11-octahydro-7-(5-hydroxy-1,5-diMethylhexyl)-6a-Methyl-2-phenyl-1H,5H-cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-di;(6aR,7R,9aR)-11-((3S,5R)-3,5-dihydroxy-2-Methylcyclohex-1-en-1-yl)-7-((R)-6-hydroxy-6-Methylheptan-2-yl)-6a-Methyl-2-phenyl-4a,5,6,6a,7,8,9,9a-octahydrocyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H,11H)-dione;1H,5H-Cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione, 11-(3,5-dihydroxy-2-Methyl-1-cyclohexen-1-yl)-4a,6,6a,7,8,9,9a,11-octahydro-7-(5-hydroxy-1,5-diMethylhexyl)-6a-Methyl-2-phenyl-, [4aR-[4aα,6aα,7α(R*),9aβ,11α(3S*,5R;IMpurity C of Calcitriol;(1H,5H-Cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione, 11-(3,5-dihydroxy-2-methyl-1-cyclohexen-1-yl)-4a,6,6a,7,8,9,9a,11-octahydro-7-(5-hydroxy-1,5-dimethylhexyl)-6a-methyl-2-phenyl-, [4aR-[4aα,6aα,7α(R*),9aβ),11α(3S*,5R*)]]- (9CI);Triazoline Adduct of pre-Calcitriol;Calcitriol Impurity 1 | | CAS: | 86307-44-0 | | MF: | C35H49N3O5 | | MW: | 591.78 | | EINECS: | | | Product Categories: | other;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 86307-44-0.mol |  |
| | pre-Calcitriol PTAD Adduct Chemical Properties |
| Boiling point | 707.5±70.0 °C(Predicted) | | density | 1.27±0.1 g/cm3(Predicted) | | storage temp. | 4°C, protect from light | | solubility | DCM, Ethyl Acetate | | form | Powder | | pka | 14.18±0.70(Predicted) | | Stability: | Light Sensitive |
| | pre-Calcitriol PTAD Adduct Usage And Synthesis |
| Uses | Calcitriol (C144500) impurity. 1α-Hydroxyvitamin D and 1α-hydroxyprevitamin D compounds were prepared in multistep syntheses via hydroxylation of previtamin D compound adducts with dienophiles. |
| | pre-Calcitriol PTAD Adduct Preparation Products And Raw materials |
|